MACRO GROUP PHARMACEUTICALS -MACRO CAPITAL financial statements, including revenue, expenses, profit, and loss

The total revenue of MCRO for the last quarter is 252.30 M EGP, and it's 38.60% higher compared to the previous quarter. The net income of Q3 23 is 68.75 M EGP.